1-4 of 4
Young-Hun Park
Close
Sort by
Journal Articles

Immediate Allogeneic Hematopoietic Cell Transplantation (HCT) in Acute Myeloid Leukemia (AML) Arising From Myelodysplastic Syndrome (MDS)

Sung-Doo Kim, M.D., Yunsuk Choi, MD, Young-Hun Park, M.D., Jae Seok Lee, MD, Dae-Young Kim, M.D., Jung-Hee Lee, M.D., Kyoo-Hyung Lee, M.D., Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ah Rang Jung, Je-Hwan Lee, M.D.
Journal: Blood
Blood (2011) 118 (21): 2031.
https://doi.org/10.1182/blood.V118.21.2031.2031
Published: 2011
Journal Articles

Retrospective Comparison of Azacitidine and Decitabine in the Treatment of Myleodysplastic Syndrome,

Je-Hwan Lee, MD, PhD, Sung-Doo Kim, MD, Yunsuk Choi, MD, Young-Hun Park, MD, Jae Seok Lee, MD, Dae-Young Kim, Jung-Hee Lee, Kyoo-Hyung Lee, Sang Min Lee, Won Sik Lee, Jung Lim Lee, Young-Don Joo
Journal: Blood
Blood (2011) 118 (21): 3809.
https://doi.org/10.1182/blood.V118.21.3809.3809
Published: 2011
Journal Articles

Prognostic Implications of CD14 Positivity in Acute Myeloid Leukemia Arising From Myleodysplastic Syndrome,

Yunsuk Choi, MD, Sungdoo Kim, MD, Young-Hun Park, MD, Jae Seok Lee, MD, Dae-Young Kim, Jung-Hee Lee, Kyoo-Hyung Lee, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ah Rang Jung, Je-Hwan Lee, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3523.
https://doi.org/10.1182/blood.V118.21.3523.3523
Published: 2011
Journal Articles

Validation of New Prognostic Model Including Comorbidities in Patients with Myleodysplastic Syndrome Receiving Hypomethylating Therapy

Young-Don Joo, Je-Hwan Lee, MD, PhD, Sung-Doo Kim, M.D., Yunsuk Choi, MD, Young-Hun Park, Jae Seok Lee, Dae-Young Kim, Jung-Hee Lee, M.D., Kyoo-Hyung Lee, Won Sik Lee, Sang Min Lee
Journal: Blood
Blood (2011) 118 (21): 1708.
https://doi.org/10.1182/blood.V118.21.1708.1708
Published: 2011